Ready to INDIGO: Vorasidenib Ushers in the Era of Isocitrate Dehydrogenase Inhibition in Low-Grade Glioma
International Journal of Radiation Oncology*Biology*Physics · 2024
DOI: 10.1016/j.ijrobp.2023.10.045 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024. Verfasst von Tyler A Lanman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Diamines, Pyridines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
- Department of Neurology, Stanford University, Palo Alto, California.
- Department of Neurology, Stanford University, Palo Alto, California. Electronic address: snagpal@stanford.edu.
Zitieren
APA
Lanman, T. A., Cao, T. Q., Miller, J. J., & Nagpal, S. (2024). Ready to INDIGO: Vorasidenib Ushers in the Era of Isocitrate Dehydrogenase Inhibition in Low-Grade Glioma. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2023.10.045
Vancouver
Lanman TA, Cao TQ, Miller JJ, Nagpal S. Ready to INDIGO: Vorasidenib Ushers in the Era of Isocitrate Dehydrogenase Inhibition in Low-Grade Glioma. International Journal of Radiation Oncology*Biology*Physics. 2024. doi:10.1016/j.ijrobp.2023.10.045
BibTeX
@article{Lanman2024,
author = {Lanman, Tyler A and Cao, Toni Q and Miller, Julie J and Nagpal, Seema},
title = {Ready to INDIGO: Vorasidenib Ushers in the Era of Isocitrate Dehydrogenase Inhibition in Low-Grade Glioma},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2024},
doi = {10.1016/j.ijrobp.2023.10.045}
}
EUVIMED